Sepai O, Henschler D, Sabbioni G
Institut für Pharmakologie und Toxikologie, Universität Würzburg, Germany.
Carcinogenesis. 1995 Oct;16(10):2583-7. doi: 10.1093/carcin/16.10.2583.
4,4'-Methylenediphenyl diisocyanate (MDI) is the most widely used isocyanate in the manufacture of polyurethanes. MDI has been implicated as one of the major causes of occupational asthma. Hydrolysis of MDI can yield 4,4'-methylenedianiline (MDA), which is a suspected human carcinogen. Thus the need to monitor occupational exposure to MDI is of great significance. The use of air monitors alone has been found to be insufficient and there is a need for sensitive markers of recent and long-term exposure. We obtained biological samples from a group of 20 workers exposed to MDI vapor during the manufacture of polyurethane products. The air levels of MDI in the factory were measured using personal, work room and work station monitors. In most cases the levels were below detection limits. The blood and urine samples were analyzed for the presence of adducts and metabolites using GC-MS methods. Urinary base-extractable metabolites were found above control levels in 15 of the 20 workers and ranged from 0.035 to 0.83 pmol MDA/ml. The level of the acetylated metabolite N'-acetyl-4,4'-methylenedianiline (AcMDA) ranged from 0.13 to 7.61 pmol/ml. The amount of MDA released after acid hydrolysis was on average 6.5 times higher than the amount of free MDA and AcMDA present in urine. MDA was detected as a hemoglobin (Hb) adduct in all of the 20 subjects. The level ranged from 70 to 710 fmol/g Hb. In one individual the Hb adduct of AcMDA was detected. This is the first time a Hb adduct of AcMDA has been detected after occupational exposure to MDI. This is a further piece of evidence for the biological availability of the suspected human carcinogen MDA from in vivo hydrolysis of MDI. Plasma albumin conjugates of MDI can cause the onset of respiratory disorders in both man and animal models. Thus we investigated the presence of plasma protein adducts. The plasma MDA levels ranged from 0.25 to 5.4 pmol/ml. Up to 120 fmol/mg were found to be covalently bound to albumin.
4,4'-亚甲基二苯基二异氰酸酯(MDI)是聚氨酯生产中使用最广泛的异氰酸酯。MDI被认为是职业性哮喘的主要病因之一。MDI水解可产生4,4'-亚甲基二苯胺(MDA),这是一种疑似人类致癌物。因此,监测职业性MDI暴露具有重要意义。仅使用空气监测仪已被发现是不够的,需要有近期和长期暴露的敏感标志物。我们从一组20名在聚氨酯产品制造过程中接触MDI蒸气的工人身上采集了生物样本。使用个人、工作间和工作站监测仪测量工厂内MDI的空气水平。在大多数情况下,水平低于检测限。使用气相色谱-质谱法分析血液和尿液样本中加合物和代谢物的存在情况。在20名工人中的15名中,发现尿中碱可提取代谢物高于对照水平,范围为0.035至0.83 pmol MDA/ml。乙酰化代谢物N'-乙酰-4,4'-亚甲基二苯胺(AcMDA)的水平范围为0.13至7.61 pmol/ml。酸水解后释放的MDA量平均比尿液中游离MDA和AcMDA的量高6.5倍。在所有20名受试者中均检测到MDA作为血红蛋白(Hb)加合物。水平范围为70至710 fmol/g Hb。在一名个体中检测到了AcMDA的Hb加合物。这是职业性接触MDI后首次检测到AcMDA的Hb加合物。这是疑似人类致癌物MDA从MDI体内水解中生物可利用性的又一证据。MDI的血浆白蛋白结合物可导致人和动物模型中呼吸系统疾病的发作。因此,我们研究了血浆蛋白加合物的存在情况。血浆MDA水平范围为0.25至5.4 pmol/ml。发现高达120 fmol/mg与白蛋白共价结合。